These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3830067

  • 1. A case of normocalcemic primary hyperparathyroidism with osteomalacia.
    Shimada I, Inaba M, Nakano H, Miki T, Nishizawa Y, Morii H.
    Endocrinol Jpn; 1986 Oct; 33(5):575-82. PubMed ID: 3830067
    [Abstract] [Full Text] [Related]

  • 2. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
    Takemia T, Sato K, Miyata M, Imaki T, Shibasaki T, Tsushima T, Demura H, Tanaka R, Obara T, Oguchi S.
    Endocr J; 1993 Feb; 40(1):121-6. PubMed ID: 7951485
    [Abstract] [Full Text] [Related]

  • 3. Hypocalcemia due to spontaneous infarction of parathyroid adenoma and osteomalacia in a patient with primary hyperparathyroidism.
    Otsuka F, Ogura T, Sato T, Hayakawa N, Mimura Y, Kishida M, Yamauchi T, Makino H.
    Endocr J; 1998 Oct; 45(5):617-23. PubMed ID: 10395241
    [Abstract] [Full Text] [Related]

  • 4. Secondary hyperparathyroidism after removal of a parathyroid adenoma.
    Jiménez-Montero JG, Lobo-Hernández E, Picado-Larios A, Molina MA.
    Endocr Pract; 2002 Oct; 8(6):429-32. PubMed ID: 15260008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL, Feig DS, Blackstein ME.
    J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
    [Abstract] [Full Text] [Related]

  • 10. Osteomalacia as a very late manifestation of primary hyperparathyroidism.
    Kaplan FS, Soffer SR, Fallon MD, Haddad JG, Dalinka M, Raffensperger EC.
    Clin Orthop Relat Res; 1988 Mar; (228):26-32. PubMed ID: 3342577
    [Abstract] [Full Text] [Related]

  • 11. Serum ionized calcium and parathyroid hormone in renal stone disease.
    Muldowney FP, Freaney R, McMullin JP, Towers RP, Spillane A, O'Connor P, O'Donohoe P, Moloney M.
    Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
    [Abstract] [Full Text] [Related]

  • 12. [Hyperparathyroidism masked by osteomalacia. Is vitamin D administration in every case of osteomalacia problem-free?].
    Zuber M, Löliger M, Boner H, Haas HG.
    Schweiz Med Wochenschr; 1986 May 10; 116(19):642-7. PubMed ID: 3715442
    [Abstract] [Full Text] [Related]

  • 13. Normocalcemic primary hyperparathyroidism with fractures.
    Wu PH, Wang CJ.
    J Arthroplasty; 2002 Sep 10; 17(6):805-9. PubMed ID: 12216040
    [Abstract] [Full Text] [Related]

  • 14. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E, Jarrah N, Sroujieh AS, Al Hadidy A, Ajlouni K.
    Endocr Pract; 2001 Sep 10; 7(5):375-8. PubMed ID: 11585374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ATYPICAL PRIMARY HYPERPARATHYROIDISM DUE TO HYPOVITAMINOSIS D.
    Gaţu AA, Velicescu C, Novac R, Mogoş V, Brănişteanu DD.
    Rev Med Chir Soc Med Nat Iasi; 2015 Sep 10; 119(2):384-9. PubMed ID: 26204641
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV, Gupta N, Kochupillai N.
    Clin Endocrinol (Oxf); 1995 Sep 10; 43(3):351-8. PubMed ID: 7586606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ, Kwon SH, Kim SW, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2003 Sep 10; 60(3):127-33. PubMed ID: 12931040
    [Abstract] [Full Text] [Related]

  • 20. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
    Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V.
    J Postgrad Med; 2012 Sep 10; 58(2):107-11. PubMed ID: 22718053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.